pinguecula: A yellowish thickened lesion on the conjunctiva near the cornea representing a benign degenerative change in the conjunctiva caused by the leakage and deposition of certain blood proteins through the permeable capillaries near the limbus.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
800 |
4. Check minimum number of eventsNone |
800 |
5. Include endpointsNone |
800 |
6. Filter based on genotype QC (FinnGen only) |
766 |
Control definitions (FinnGen only)
- Control exclude
- H7_CONJUNCTIVA
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H11
- Name in latin
- Degenerationes et deposita conjunctivae
Similar endpoints
↥List of similar endpoints to
conjunctival degenerations and deposits
based on the number of shared cases.
Similar with more cases:
- Other disorders of conjunctiva
- Disorders of conjunctiva
- Diseases of the eye and adnexa
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5600 | 3529 | 2024 |
| Only index persons | 5007 | 3200 | 1807 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.08 | 0.10 | 0.06 |
| Only index persons | 0.10 | 0.12 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 53.72 | 53.94 | 53.55 |
| Only index persons | 52.74 | 52.84 | 52.55 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 766 | 489 | 277 |
| Unadjusted period prevalence (%) | 0.16 | 0.17 | 0.13 |
| Median age at first event (years) | 53.48 | 51.86 | 56.35 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 800
- Matched controls
- 8000
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
+∞
307.7
781
*
H04.10
ICD-10 Finland
Dry eye syndrome
6.5
107.5
210
413
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
4.9
100.3
554
2517
CFC00
NOMESCO Finland
Excision of lesion of conjunctiva
156.1
80.7
84
6
S01GX01
ATC
cromoglicic acid; ophthalmic
4.7
75.9
222
608
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
11.9
63.1
66
60
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
2.6
37.0
359
1917
S01KA02
ATC
hypromellose; ophthalmic
9.2
34.8
43
49
S01BA01
ATC
dexamethasone; ophthalmic
5.9
33.3
62
112
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
4.6
28.9
72
168
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.7
28.9
195
857
S01GX02
ATC
levocabastine; ophthalmic
5.1
27.6
60
125
H57.1
ICD-10 Finland
Ocular pain
5.3
26.2
54
107
S01BC03
ATC
diclofenac; ophthalmic
6.5
24.7
41
66
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
28.6
24.6
33
12
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
4.4
24.3
64
156
H11.0
ICD-10 Finland
Pterygium
57.9
24.2
28
5
H02AB06
ATC
prednisolone; systemic
2.1
22.7
424
2808
CF2S4
NOMESCO Finland
Photography of conjunctiva
118.3
21.7
23
*
L01BA01
ATC
methotrexate; systemic
4.5
21.6
54
126
F01
ICPC
Eye pain
5.5
20.8
41
78
P01BA02
ATC
hydroxychloroquine; oral
2.9
19.9
99
366
3725A
ICD-9 Finland
Disorders of conjunctiva, Conjunctival degenerations and deposits
+∞
19.9
19
*
H10.4
ICD-10 Finland
Chronic conjunctivitis
107.7
19.6
21
*
H16.9
ICD-10 Finland
Keratitis, unspecified
7.6
19.6
28
38
S01GX08
ATC
ketotifen; ophthalmic
5.4
19.6
39
75
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.1
19.2
54
138
H15.1
ICD-10 Finland
Episcleritis
7.6
18.3
26
35
S01GX05
ATC
lodoxamide; ophthalmic
23.4
17.8
25
11
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.6
17.8
114
481
H16.0
ICD-10 Finland
Corneal ulcer
3.7
17.5
58
167
S01BA07
ATC
fluorometholone; ophthalmic
7.6
17.5
25
34
R07.4
ICD-10 Finland
Chest pain, unspecified
2.0
17.4
266
1601
CD2S4
NOMESCO Finland
Photography of eye
24.7
17.4
24
10
A02BC03
ATC
lansoprazole; oral
2.0
17.3
278
1702
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
17.2
118
514
CFA20
NOMESCO Finland
Biopsy of conjunctiva
64.8
16.8
19
*
E0000UV, ,
ATC
1.9
16.7
342
2263
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
15.6
266
1652
N03AX16
ATC
[U] pregabalin
2.0
15.4
216
1255
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
15.1
202
1153
H00.1
ICD-10 Finland
Chalazion
3.8
15.0
47
130
H01.0
ICD-10 Finland
Blepharitis
3.3
15.0
58
185
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
4.9
14.8
33
70
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
12.2
14.6
26
22
A02BC05
ATC
esomeprazole; systemic
1.8
14.1
348
2405
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
14.1
296
1949
S01AD03
ATC
aciclovir; ophthalmic
3.8
13.7
43
119
3401
FHL
Removal of local modification or taking a specimen in the operating room
+∞
13.6
13
*
D86.0
ICD-10 Finland
Sarcoidosis of lung
6.2
13.5
23
38
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
2.8
13.3
71
272
S01AX11
ATC
[U] ofloxacin
3.7
13.3
42
117
S01AA01
ATC
chloramphenicol; ophthalmic
3.2
13.3
53
172
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
13.1
159
871
A02BC01
ATC
omeprazole; systemic
1.8
13.0
243
1537
M54.4
ICD-10 Finland
Lumbago with sciatica
2.0
12.9
155
846
G44.2
ICD-10 Finland
Tension-type headache
2.2
12.9
128
651
N02AX02
ATC
tramadol; systemic, rectal
1.7
12.8
367
2627
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
+∞
12.5
12
*
S01GX04
ATC
nedocromil; ophthalmic
10.7
12.3
23
22
M79.0
ICD-10 Finland
Rheumatism, unspecified
3.4
12.1
43
130
A06AC01
ATC
ispaghula (psylla seeds); oral
1.8
11.8
234
1501
S01XA18
ATC
ciclosporin; ophthalmic
16.7
11.7
18
11
SAA01
NOMESCO Finland
Simple examination of mouth
1.7
11.6
553
4499
R06.0
ICD-10 Finland
Dyspnoea
1.8
11.6
227
1450
M01AX17
ATC
nimesulide; oral
1.8
11.6
218
1376
J02AC01
ATC
fluconazole; systemic
1.7
11.5
312
2182
Z71.8
ICD-10 Finland
Other specified counselling
1.8
11.5
243
1587
R01AD01
ATC
beclometasone; nasal
2.0
11.4
134
724
N06AA09
ATC
amitriptyline; systemic
2.2
11.2
98
473
M54.6
ICD-10 Finland
Pain in thoracic spine
2.5
11.0
73
312
H11.8
ICD-10 Finland
Other specified disorders of conjunctiva
44.0
10.9
13
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.8
10.9
218
1396
R42
ICD-10 Finland
Dizziness and giddiness
1.8
10.7
196
1222
H02AB04
ATC
methylprednisolone; systemic
2.0
10.7
124
666
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
2.0
10.6
129
704
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
10.6
285
1979
H11.3
ICD-10 Finland
Conjunctival haemorrhage
3.6
10.5
35
101
S01GX09
ATC
olopatadine; ophthalmic
4.9
10.5
23
48
CCC00
NOMESCO Finland
Occlusion of lacrimal punctum or canaliculus
+∞
10.4
10
*
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.4
10.3
71
308
K59.09
ICD-10 Finland
Constipation, unspecified
2.5
10.3
65
271
R06AE07
ATC
cetirizine; oral
1.6
10.2
324
2343
A01AB09
ATC
miconazole; local oral
2.3
10.2
84
395
XCK00
NOMESCO Finland
Perimetry
2.6
10.2
61
248
WZC30
NOMESCO Finland
Teaching
1.9
10.1
136
768
XCK10
NOMESCO Finland
Photography of fundus of eye
2.2
10.1
88
423
A07EC01
ATC
sulfasalazine; oral, rectal
2.4
10.1
75
337
A02BC02
ATC
pantoprazole; systemic
1.7
10.0
544
4483
H19.3
ICD-10 Finland
Keratitis and keratoconjunctivitis in other diseases classified elsewhere
40.6
10.0
12
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
9.9
177
1095
K07.63
ICD-10 Finland
Pain in the jaw joint UNS
4.5
9.9
24
55
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.3
9.8
78
361
J05AB01
ATC
aciclovir; systemic
1.8
9.8
181
1129
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
9.8
152
900
UJF32
NOMESCO Finland
Coloscopy
1.7
9.7
224
1486
R06AX22
ATC
ebastine; oral
1.9
9.7
131
740
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
2.2
9.6
80
378
M03BX02
ATC
tizanidine; oral
1.6
9.4
483
3899
R03AC02
ATC
salbutamol; inhalant
1.6
9.3
422
3301
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
9.3
330
2437
K07.60
ICD-10 Finland
Snapping jaw
2.7
9.3
49
187
M54.5
ICD-10 Finland
Low back pain
1.6
9.3
280
1989
M25.5
ICD-10 Finland
Pain in joint
1.6
9.1
252
1750
S01GX06
ATC
emedastine; ophthalmic
11.6
9.1
16
14
F70
ICPC
Conjunctivitis infectious
3.7
9.1
28
77
G51.0
ICD-10 Finland
Bell palsy
3.7
9.1
28
77
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
37.1
9.0
11
*
S01BA04
ATC
prednisolone; ophthalmic
3.9
9.0
26
68
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
2.6
8.9
51
203
CG2S4
NOMESCO Finland
Photography of cornea
12.7
8.9
15
12
J01FA10
ATC
azithromycin; systemic
1.6
8.9
427
3373
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
8.9
294
2131
S01ED01
ATC
timolol; ophthalmic
3.2
8.9
34
108
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
9.6
8.8
17
18
A02BA02
ATC
ranitidine; systemic
1.7
8.7
167
1049
A01AB04
ATC
amphotericin B; local oral
2.6
8.7
49
193
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
8.7
315
2328
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.4
8.6
61
268
L04AA13
ATC
[U] leflunomide
3.6
8.6
28
80
L04AA01
ATC
[U] ciclosporin
7.0
8.6
20
29
R03BA01
ATC
beclometasone; inhalant
1.9
8.5
114
642
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
8.5
176
1131
SAA03
NOMESCO Finland
Extended examination of mouth
1.6
8.5
290
2114
M01CB01
ATC
sodium aurothiomalate; parenteral
5.0
8.4
18
37
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.9
8.4
119
683
CGE50
NOMESCO Finland
Excision of pterygium
+∞
8.3
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
8.3
133
792
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
8.2
56
242
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
8.2
89
465
L03
ICPC
Low back symptom/complaint
1.6
8.2
217
1483
L02
ICPC
Back symptom/complaint
2.1
8.1
83
425
KMAK, ,
NOMESCO Finland
1.5
8.1
378
2945
R03AC03
ATC
terbutaline; inhalant
1.9
8.1
108
608
SFA10
NOMESCO Finland
One-surface restoration
1.5
8.0
407
3229
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.0
7.9
93
500
R01AD09
ATC
mometasone; nasal
1.5
7.9
333
2534
R01AD58
ATC
fluticasone, combinations; nasal
1.7
7.9
162
1037
SPAT1216
SPAT
Assessment of functional ability
1.8
7.9
134
813
S06.0
ICD-10 Finland
Concussion
2.0
7.8
90
481
J01AA02
ATC
doxycycline; systemic
1.6
7.8
610
5308
F45.8
ICD-10 Finland
Other somatoform disorders
2.4
7.8
52
223
RF420, ,
NOMESCO Finland
4.2
7.8
20
48
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.6
7.8
216
1493
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
7.7
139
856
RD211, ,
NOMESCO Finland
2.6
7.7
44
175
M05BA07
ATC
risedronic acid; oral
3.0
7.7
34
118
SPAT1325
SPAT
Vaccination
1.6
7.7
260
1882
M01AX01
ATC
nabumetone; oral
2.6
7.6
44
176
L04AX03
ATC
methotrexate; systemic
2.0
7.6
84
442
M79.1
ICD-10 Finland
Myalgia
1.8
7.6
116
680
SDA01
NOMESCO Finland
Periodontal treatment, very brief
1.6
7.6
200
1363
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.5
128
775
C05AA08
ATC
fluocortolone; rectal, topical
1.8
7.5
114
667
M79.7
ICD-10 Finland
Fibromyalgia
2.9
7.5
34
120
A02BA04
ATC
nizatidine; systemic
2.1
7.5
70
347
N05CF01
ATC
zopiclone; oral
1.6
7.4
262
1910
SHA02
NOMESCO Finland
Stomatognathic treatment, basic
2.3
7.3
56
255
J01FA06
ATC
roxithromycin; oral
1.5
7.3
311
2359
N03AX12
ATC
[U] gabapentin; oral
1.7
7.3
137
853
H16.2
ICD-10 Finland
Keratoconjunctivitis
9.5
7.3
14
15
M01AH05
ATC
etoricoxib; oral
1.5
7.3
470
3886
R83
ICPC
Respiratory infection other
1.7
7.3
163
1065
H10.5
ICD-10 Finland
Blepharoconjunctivitis
5.9
7.3
19
33
F29
ICPC
Eye symptom/complaint other
2.0
7.2
77
400
SPAT1153
SPAT
Removal of sutures
1.5
7.2
258
1884
R03AC13
ATC
formoterol; inhalant
2.5
7.2
46
193
D07AC13
ATC
mometasone; topical
1.6
7.2
220
1550
S29
ICPC
Skin symptom/complaint other
1.7
7.1
146
931
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.7
7.1
38
146
N02BE01
ATC
paracetamol; systemic, rectal
1.8
7.1
703
6394
M48.0
ICD-10 Finland
Spinal stenosis
1.8
7.1
111
655
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
7.1
113
671
H10.8
ICD-10 Finland
Other conjunctivitis
12.2
7.1
12
10
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.2
7.1
62
299
R51.80
ICD-10 Finland
Headache
1.8
7.1
119
718
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
7.0
145
926
L01
ICPC
Neck symptom/complaint
1.8
7.0
116
697
A03FA02
ATC
cisapride; oral, rectal
2.1
7.0
65
321
R53
ICD-10 Finland
Malaise and fatigue
1.6
7.0
180
1218
D07BC01
ATC
betamethasone and antiseptics; topical
1.9
7.0
94
530
H02.3
ICD-10 Finland
Blepharochalasis
2.2
6.9
60
288
E000001, ,
ATC
1.7
6.9
142
906
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
3.6
6.9
22
62
Z01.2
ICD-10 Finland
Dental examination
1.5
6.9
321
2475
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.1
6.9
65
323
R07.3
ICD-10 Finland
Other chest pain
1.9
6.9
89
495
D07AC01
ATC
betamethasone; topical
1.5
6.9
269
2001
A07AA02
ATC
nystatin; oral
2.3
6.8
53
243
Z3229
NOMESCO Finland
Other healthcare associate professional
2.1
6.8
68
345
F02
ICPC
Red eye
2.6
6.8
37
144
H06.2
ICD-10 Finland
Dysthyroid exophthalmos
40.4
6.8
8
*
J01CA04
ATC
amoxicillin; systemic
1.6
6.8
616
5436
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
2.3
6.8
52
238
L04AD01
ATC
ciclosporin; systemic
3.9
6.7
19
49
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.5
6.7
344
2701
M01AH01
ATC
celecoxib; oral
1.7
6.7
148
963
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.5
6.7
401
3246
D19
ICPC
Teeth/gum symptom/complaint
1.6
6.7
203
1427
R13
ICD-10 Finland
Dysphagia
2.1
6.6
59
287
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
3.4
6.6
23
69
ZXA05
NOMESCO Finland
Left side
1.6
6.6
196
1370
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.6
6.6
195
1362
RF410, ,
NOMESCO Finland
4.2
6.6
17
41
SPAT1263
SPAT
Sampling
1.5
6.6
317
2456
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.1
6.6
58
281
N06AX11
ATC
mirtazapine; oral
1.5
6.5
259
1927
L04AX01
ATC
azathioprine; systemic
2.6
6.5
38
153
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.8
6.5
93
534
C08CA13
ATC
lercanidipine; oral
1.7
6.5
117
720
281
Kela drug reimbursment
Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab
3.3
6.5
24
75
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.1
6.5
57
276
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
14.4
6.4
10
7
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.8
6.4
108
653
R01AD12
ATC
fluticasone furoate; nasal
1.5
6.3
208
1485
G43.9
ICD-10 Finland
Migraine, unspecified
2.4
6.3
42
180
J45.1
ICD-10 Finland
Nonallergic asthma
2.1
6.3
59
292
M47.9
ICD-10 Finland
Spondylosis, unspecified
2.7
6.3
32
120
M70.6
ICD-10 Finland
Trochanteric bursitis
1.7
6.3
111
678
L04AA06
ATC
mycophenolic acid; systemic
3.9
6.3
18
47
J01MA02
ATC
ciprofloxacin; systemic
1.5
6.3
289
2213
R05
ICD-10 Finland
Cough
1.6
6.3
162
1094
H19.2
ICD-10 Finland
Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
+∞
6.3
6
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.9
6.3
79
436
7140A
ICD-9 Finland
Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]
5.1
6.2
18
36
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
5.1
6.2
18
36
R1250
NOMESCO Finland
Evaluation of functional capability
3.2
6.2
24
77
D07CC01
ATC
betamethasone and antibiotics; topical
1.8
6.2
99
588
L28
ICPC
Limited function/disability (L)
1.6
6.2
140
915
K59.0
ICD-10 Finland
Constipation
2.2
6.2
48
221
ZYC01
NOMESCO Finland
Remote contact by phone
2.2
6.1
50
235
M77.9
ICD-10 Finland
Enthesopathy, unspecified
2.8
6.1
29
105
I84.5
ICD-10 Finland
External hemorrhoids without complication
2.8
6.1
30
111
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
6.1
139
911
L08
ICPC
Shoulder symptom/complaint
1.6
6.1
168
1153
A01
ICPC
Pain general/multiple sites
1.9
6.0
73
397
Z00.0
ICD-10 Finland
General medical examination
1.6
6.0
152
1020
S01FA04
ATC
cyclopentolate; ophthalmic
6.1
6.0
15
25
R07.0
ICD-10 Finland
Pain in throat
2.2
6.0
49
230
R05
ICPC
Cough
1.6
6.0
179
1249
R01AD05
ATC
budesonide; nasal
2.1
6.0
59
298
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
302
2107
1.70
11.16
3.0
2.5
64.65
99.36
u/l
0.43
283
1936
357
2619
1.66
10.79
3.6
3.7
30.94
51.93
ng/l
0.88
258
1895
576
4894
1.63
8.65
5.2
4.2
13.45
12.73
mm/h
0.59
543
4487
468
3791
1.57
8.60
9.4
9.2
4.02
4.08
e9/l
0.22
412
3322
21
53
4.04
7.65
1.2
1.3
—
—
—
0
0
24
70
3.50
7.16
1.7
1.2
—
—
—
0
0
474
3937
1.50
7.12
5.0
4.6
6.85
6.74
mmol/l
0.47
441
3692
588
5115
1.56
7.08
4.6
4.0
14.98
14.89
pmol/l
0.42
538
4595
592
5163
1.56
7.00
8.2
7.7
78.95
78.70
u/l
0.05
564
4831
321
2493
1.48
6.57
5.5
4.0
—
—
—
0
0
401
3263
1.46
6.40
5.3
3.8
0.00
0.01
estimate
0.50
71
594
394
3219
1.44
6.03
5.3
3.8
0.00
0.00
estimate
0.74
76
660
238
1767
1.49
5.98
5.6
4.2
0.00
0.01
estimate
0.69
69
601
709
6534
1.75
5.94
17.2
14.5
20.71
23.90
mg/l
1.83
583
5170
274
2096
1.47
5.91
2.4
2.1
120.90
225.84
u/l
2.46
256
1970
92
545
1.78
5.81
3.0
2.7
55.70
64.44
ml/min/173m2
1.44
30
229
393
3227
1.43
5.75
7.0
5.1
0.00
0.00
estimate
0.50
68
612
199
1442
1.51
5.57
5.6
4.2
1.01
1.02
kg/l
1.17
27
207
501
4358
1.40
4.93
5.6
4.6
2148.38
2905.65
e6/l
—
8
74
666
6120
1.53
4.75
5.6
4.8
1.87
1.95
mu/l
1.15
613
5550
338
2768
1.38
4.72
2.4
2.3
78.94
77.81
nmol/l
0.31
306
2443
32
140
2.34
4.67
1.6
1.2
—
—
—
0
0
430
3686
1.36
4.40
2.8
2.7
—
—
—
0
0
415
3545
1.35
4.31
6.0
6.4
11.13
11.15
umol/l
0.01
392
3360
44
228
1.98
4.24
1.6
1.2
0.50
1.51
u/ml
—
7
20
256
2032
1.38
4.23
2.7
3.0
955.45
1244.26
ng/l
0.88
227
1736
156
1137
1.46
4.15
1.4
1.3
43.70
34.83
iu/ml
0.28
58
368
124
868
1.51
4.03
7.9
7.4
—
—
—
0
0
290
2374
1.35
3.87
3.9
3.2
—
—
—
0
0
344
2900
1.33
3.73
4.4
4.6
35.66
35.37
g/l
0.45
324
2700
189
1456
1.39
3.68
1.7
1.7
80864669.76
11455277.55
pmol/l
0.63
162
1196
148
1094
1.43
3.64
1.4
1.2
8.78
10.73
u/ml
0.15
68
420
37
198
1.91
3.30
1.6
1.5
250.03
288.70
ug/g
0.46
22
121
472
4210
1.30
3.18
3.6
3.1
48.50
48.93
u/l
0.04
441
3900
15
55
2.76
3.17
2.1
2.6
—
—
—
0
0
32
166
1.97
3.13
1.7
1.2
8.20
3.61
u/ml
—
6
16
32
168
1.94
3.04
1.7
1.2
2.79
3.18
u/ml
—
8
25
28
140
2.04
3.04
1.7
1.2
4.68
1.02
u/ml
—
5
9
323
2758
1.29
3.01
2.8
2.7
104.42
129.70
ug/l
2.19
299
2521
386
3372
1.28
3.00
8.2
6.5
1.22
1.22
mmol/l
0.70
344
2866
179
1420
1.34
2.84
1.8
1.6
0.72
1.22
mg/l
6.44
142
1114
362
3155
1.27
2.81
2.6
2.5
—
—
—
0
0
719
6866
1.47
2.73
18.8
16.9
3.97
3.97
mmol/l
0.00
703
6671
717
6848
1.45
2.67
18.9
16.8
139.54
139.74
mmol/l
1.27
702
6663
363
3183
1.26
2.62
12.9
15.0
1.21
1.26
inr
0.46
102
917
102
749
1.41
2.61
2.1
2.1
152.22
129.72
ug/g
0.30
80
597
205
1680
1.30
2.56
2.9
2.6
5393.69
5955.40
umol/l
0.06
179
1459
11
37
3.00
2.49
3.1
1.9
—
—
—
0
0
83
593
1.45
2.47
1.9
2.4
3.38
7.28
ug/l
3.70
68
521
7
17
4.14
2.36
1.0
1.1
—
—
—
0
0
350
3082
1.24
2.36
7.1
5.7
57.17
57.24
%
0.04
326
2887
46
700
0.64
2.34
2.8
3.4
—
—
—
0
0
24
127
1.92
2.28
1.5
1.2
52.07
41.47
u/ml
—
6
16
59
401
1.51
2.26
1.5
1.4
—
—
—
0
0
10
35
2.88
2.21
1.0
1.1
—
10.25
—
0
11
35
211
1.69
2.20
3.0
2.8
—
—
—
0
0
77
561
1.41
2.09
3.0
2.8
67.27
66.72
g/l
0.29
70
508
10
38
2.65
2.01
1.0
1.0
—
—
—
0
0
29
172
1.71
1.95
2.0
1.3
—
—
—
0
0
30
181
1.68
1.91
2.2
2.3
286.87
96.21
ug/min
0.72
15
106
349
3122
1.21
1.91
7.2
6.0
28.29
27.68
%
0.44
325
2925
139
1125
1.29
1.90
3.4
2.7
1.31
1.29
e6/l
0.02
98
645
34
213
1.62
1.88
2.0
2.0
—
—
—
0
0
6
17
3.55
1.84
1.0
1.1
—
—
—
0
0
6
17
3.55
1.84
4.0
1.8
—
—
—
0
0
6
17
3.55
1.84
1.0
1.1
—
—
—
0
0
32
199
1.63
1.83
1.3
1.3
—
—
—
0
0
41
273
1.53
1.77
1.9
1.8
—
—
—
0
0
56
399
1.43
1.75
2.1
1.7
—
—
—
0
0
9
36
2.52
1.74
1.3
1.3
—
—
—
0
0
61
448
1.39
1.62
2.2
1.8
—
—
—
0
0
132
1084
1.26
1.61
1.8
1.8
—
—
—
0
0
70
528
1.36
1.59
4.3
3.5
106.70
83.05
ng/l
0.51
55
466
261
2305
1.20
1.58
2.8
3.5
2.35
2.36
mmol/l
0.52
227
2026
341
3084
1.18
1.57
7.7
5.8
1.21
1.21
mmol/l
0.00
308
2785
65
486
1.37
1.56
1.7
1.6
—
—
—
0
0
118
962
1.27
1.54
1.6
1.4
—
—
—
0
0
210
1822
1.21
1.53
3.6
3.1
0.40
0.54
e6/l
0.35
166
1386
305
2738
1.18
1.53
2.1
2.0
97.25
95.92
pmol/l
0.18
154
1372
193
1664
1.21
1.50
2.3
2.1
3.04
3.12
mg/l
0.18
171
1407
95
756
1.29
1.50
1.7
1.8
—
—
—
0
0
10
45
2.24
1.47
1.0
1.1
216.20
230.58
mg/l
—
10
38
10
45
2.24
1.47
1.0
1.3
—
—
—
0
0
10
45
2.24
1.47
1.0
1.3
—
—
—
0
0
30
196
1.55
1.45
1.5
1.4
—
—
—
0
0
17
95
1.81
1.44
1.1
1.0
—
—
—
0
0
744
7257
1.36
1.43
25.5
21.5
39.96
39.88
%
0.14
704
6759
744
7261
1.35
1.38
25.6
21.4
252.71
250.32
e9/l
0.47
732
7072
72
559
1.32
1.37
3.9
3.9
1.23
1.23
mmol/l
0.07
65
478
8
163
0.49
1.37
2.9
1.9
214.13
188.63
%
—
8
156
744
7263
1.35
1.36
25.7
21.4
4.44
4.45
e12/l
0.20
731
7053
42
299
1.43
1.36
1.0
1.0
—
—
—
0
0
37
257
1.46
1.36
1.9
1.7
—
—
—
0
0
5
17
2.95
1.36
3.8
1.8
—
—
—
0
0
14
75
1.88
1.35
1.1
1.5
—
—
—
0
0
14
75
1.88
1.35
1.1
1.5
—
—
—
0
0
28
184
1.54
1.33
1.9
1.6
—
—
—
0
0
744
7266
1.34
1.33
25.8
21.6
134.07
134.21
g/l
0.10
738
7154
0
40
0.00
1.33
0.0
1.7
—
—
—
0
0
0
41
0.00
1.31
0.0
1.7
—
—
—
0
0
29
194
1.51
1.28
1.6
1.6
20.00
0.09
iu/ml
—
5
42
23
146
1.59
1.27
1.3
1.1
—
—
—
0
0
23
146
1.59
1.27
1.7
1.3
—
—
—
0
0
9
44
2.06
1.27
1.0
1.5
—
290.00
—
0
5
677
6550
1.22
1.23
5.0
4.5
4.62
4.69
mmol/l
0.82
626
6030
11
56
1.98
1.22
1.7
1.1
—
—
—
0
0
16
93
1.74
1.22
1.3
1.8
—
—
—
0
0
56
430
1.33
1.18
1.3
1.2
176.04
154.63
iu/ml
0.11
20
172
183
1608
1.18
1.16
1.5
1.5
21.59
20.79
nmol/l
0.29
153
1340
689
6688
1.22
1.14
5.4
5.1
2.69
2.75
mmol/l
1.09
637
6115
650
6277
1.19
1.14
14.6
13.7
79.11
78.89
ml/min/173m2
0.10
541
5189
76
612
1.27
1.13
5.1
3.3
1.83
2.12
mmol/l
0.39
64
502
640
6173
1.18
1.13
6.5
5.9
40.17
40.13
mmol/mol
0.04
600
5698
11
58
1.91
1.12
2.2
2.2
650.40
586.94
ml
—
5
36
105
880
1.22
1.10
7.6
5.0
1.02
1.02
mmol/l
0.03
99
801
7
31
2.27
1.10
1.1
3.3
739.29
932.10
u/ml
—
7
31
158
1378
1.18
1.09
2.7
2.6
5.54
6.56
e6/l
0.33
139
1249
7
32
2.20
1.08
1.3
1.4
—
—
—
0
0
649
6276
1.18
1.07
4.5
4.0
1.31
1.28
mmol/l
0.37
597
5702
17
105
1.63
1.06
1.1
1.6
—
—
—
0
0
17
105
1.63
1.06
1.1
1.6
—
—
—
0
0
91
757
1.23
1.04
3.3
4.2
12.09
26.57
ug/l
0.59
74
633
14
83
1.70
1.02
1.3
1.1
—
13.39
—
0
7
717
7006
1.23
0.99
12.7
10.7
25.81
25.19
u/l
0.50
696
6740
48
372
1.31
0.98
1.2
1.2
151.16
145.32
u/ml
0.03
42
340
590
5679
1.15
0.96
18.2
17.4
15.52
15.17
%
0.63
583
5587
26
358
0.72
0.90
6.6
7.2
25.69
24.87
mmol/l
1.10
26
353
74
614
1.23
0.89
2.0
2.0
361.03
373.25
nmol/l
0.22
69
564
141
1246
1.16
0.85
1.7
1.8
1239.80
1215.05
nmol/l
0.09
118
927
667
6497
1.16
0.83
5.0
4.7
5.91
5.98
mmol/l
0.74
614
5869
89
758
1.20
0.83
1.8
1.8
—
—
—
0
0
14
89
1.58
0.81
1.1
1.1
—
—
—
0
0
38
295
1.30
0.80
1.4
1.3
—
—
—
0
0
163
1809
0.88
0.79
1.6
1.6
1.41
1.37
mmol/l
0.28
133
1500
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
6
33
1.82
0.79
3.3
2.2
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
149.50
—
0
25
667
6506
1.15
0.77
4.8
4.5
1.51
1.50
mmol/l
0.20
616
5949
32
244
1.32
0.76
3.8
2.0
—
—
—
0
0
18
125
1.45
0.73
1.1
1.4
—
—
—
0
0
18
125
1.45
0.73
1.1
1.4
—
—
—
0
0
216
1993
1.11
0.68
3.7
3.2
32.53
96.05
e6/l
1.12
175
1536
7
120
0.58
0.68
2.4
3.7
58.29
59.70
%
—
7
120
37
294
1.27
0.67
2.4
1.7
1.53
1.56
g/l
0.08
30
260
29
223
1.31
0.67
1.4
1.4
—
—
—
0
0
49
406
1.22
0.63
2.9
3.2
2.00
1.89
mmol/l
0.06
35
307
12
176
0.68
0.62
2.5
1.7
96.50
90.99
%
0.45
12
171
47
390
1.22
0.61
3.5
3.2
4.40
4.54
pmol/l
0.42
39
339
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
17
122
1.40
0.60
1.5
1.2
—
—
—
0
0
15
105
1.44
0.60
1.4
1.7
—
—
—
0
0
142
1289
1.12
0.60
2.8
3.0
2.44
2.46
mmol/l
0.82
126
1134
86
755
1.16
0.60
2.5
2.7
7.68
9.36
umol/l
0.33
75
662
153
1396
1.12
0.59
1.4
1.2
3.23
1.79
u/ml
0.35
44
387
65
558
1.18
0.59
6.5
6.9
10.36
9.63
mmol/l
0.35
60
526
107
955
1.14
0.59
2.5
2.3
2.42
2.34
g/l
0.91
100
881
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
7
116
0.60
0.58
2.4
3.4
3.80
4.42
e9/l
—
7
116
6
38
1.58
0.54
1.0
1.5
234.78
168.99
pmol/l
—
6
38
176
1629
1.10
0.53
2.5
2.2
—
—
—
0
0
6
39
1.54
0.53
1.7
1.3
—
—
—
0
0
22
170
1.30
0.52
2.9
2.9
1.50
1.59
mg/l
0.17
17
151
24
188
1.29
0.51
1.3
1.1
—
—
—
0
0
9
65
1.39
0.50
1.1
1.3
—
—
—
0
0
9
65
1.39
0.50
1.0
1.2
—
—
—
0
0
154
1420
1.10
0.50
4.4
4.3
23.49
21.66
%
0.75
81
707
23
180
1.29
0.50
1.7
1.6
—
—
—
0
0
59
676
0.86
0.49
1.6
1.8
1.42
1.51
%
0.53
54
590
13
93
1.40
0.48
1.0
1.1
—
—
—
0
0
100
903
1.12
0.48
2.5
2.3
21.26
22.41
%
0.38
86
772
191
1787
1.09
0.47
4.9
4.9
1.68
3.06
ug/l
1.81
176
1583
135
1246
1.10
0.44
4.1
3.9
50.66
359.68
ng/l
3.88
99
976
10
69
1.45
0.44
1.7
2.3
—
—
—
0
0
20
157
1.28
0.43
1.2
1.4
—
—
—
0
0
20
157
1.28
0.43
1.5
1.8
8.50
5.63
iu/l
—
9
49
34
285
1.20
0.43
3.4
3.3
24.59
4728.17
u/ml
0.78
27
253
224
2119
1.08
0.42
3.5
3.5
31.21
31.57
u/l
0.07
217
2011
6
93
0.64
0.42
1.0
1.7
—
—
—
0
0
115
1056
1.10
0.42
2.7
2.3
12.66
12.92
umol/l
0.15
108
976
23
185
1.25
0.42
1.3
1.1
—
—
—
0
0
8
58
1.38
0.41
1.0
1.1
—
—
—
0
0
0
15
0.00
0.41
0.0
1.0
—
102.88
—
0
8
0
15
0.00
0.41
0.0
1.0
—
88.25
—
0
8
0
15
0.00
0.41
0.0
1.5
—
6.07
—
0
9
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
17
0.00
0.40
0.0
1.6
—
133.59
—
0
17
21
168
1.26
0.40
1.7
1.6
—
—
—
0
0
0
18
0.00
0.40
0.0
1.3
—
0.68
—
0
12
7
106
0.66
0.39
1.1
1.2
—
—
—
0
0
11
148
0.74
0.39
1.0
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
214
0.79
0.38
3.0
2.4
0.48
0.35
u/ml
—
7
115
8
113
0.71
0.37
1.0
1.8
—
—
—
0
0
6
42
1.43
0.35
1.5
1.3
6.97
6.66
u/l
—
6
36
59
528
1.13
0.35
2.8
2.9
148.77
207.52
ng/l
1.01
47
483
6
88
0.68
0.33
1.0
1.2
—
2.64
—
0
25
23
192
1.20
0.32
1.4
1.7
—
—
—
0
0
18
147
1.23
0.31
1.1
1.8
—
—
—
0
0
45
504
0.89
0.30
1.9
1.8
—
—
—
0
0
83
766
1.09
0.30
8.7
7.1
1.49
1.23
mmol/l
0.43
68
615
110
1029
1.08
0.29
1.3
1.4
—
—
—
0
0
7
56
1.25
0.29
1.1
1.0
—
—
—
0
0
7
57
1.23
0.29
1.0
1.7
—
—
—
0
0
7
57
1.23
0.29
1.0
1.7
—
—
—
0
0
7
57
1.23
0.29
1.0
1.7
—
—
—
0
0
113
1060
1.08
0.28
3.6
2.9
1.58
2.70
e6/l
1.76
72
581
45
403
1.12
0.28
1.4
1.6
—
—
—
0
0
8
64
1.25
0.27
2.3
1.6
—
—
—
0
0
26
224
1.17
0.27
2.0
1.7
—
—
—
0
0
8
65
1.23
0.27
1.0
1.1
—
—
—
0
0
8
67
1.20
0.26
1.0
1.1
—
—
—
0
0
5
73
0.68
0.26
1.2
1.7
—
—
—
0
0
14
170
0.82
0.25
1.8
1.5
—
—
—
0
0
18
151
1.20
0.25
1.1
1.7
—
—
—
0
0
82
768
1.08
0.22
8.8
7.1
5.07
5.13
kpa
0.25
77
736
82
768
1.08
0.22
8.8
7.1
11.76
12.39
kpa
0.70
77
739
5
41
1.22
0.22
2.0
1.7
—
—
—
0
0
42
382
1.10
0.22
2.1
2.2
12.34
13.01
nmol/l
0.18
32
338
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
23.99
—
0
11
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
10
0.00
0.21
0.0
2.1
—
0.50
—
0
10
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
23
201
1.15
0.21
2.0
1.6
—
—
—
0
0
5
43
1.16
0.21
1.4
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
28.70
—
0
9
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
6
49
1.23
0.20
1.0
1.1
—
—
—
0
0
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
6
50
1.20
0.19
1.0
1.1
—
—
—
0
0
11
133
0.82
0.19
2.1
1.6
—
—
—
0
0
6
52
1.15
0.19
2.7
2.2
13.67
13.21
%
—
6
52
7
61
1.15
0.17
1.0
1.1
—
—
—
0
0
106
1013
1.05
0.17
2.8
3.0
0.63
0.77
ug/l
1.94
76
682
169
1637
1.04
0.16
3.4
3.7
92.13
90.52
%
0.37
160
1596
8
71
1.13
0.16
2.4
3.6
—
—
—
0
0
18
160
1.13
0.14
2.2
1.3
—
—
—
0
0
12
103
1.17
0.13
2.0
3.4
1.25
1.56
%
0.17
12
92
8
99
0.81
0.13
3.7
5.1
311.50
380.63
umol/l
—
8
86
13
147
0.88
0.11
1.8
2.2
123.50
127.54
g/l
—
8
111
206
2022
1.03
0.10
3.4
3.2
619.52
314.20
mg/l
0.34
140
1252
5
46
1.09
0.09
1.4
1.2
10.20
11.17
u/l
—
5
41
16
146
1.10
0.08
2.4
3.0
0.89
0.83
nmol/l
0.14
11
113
11
123
0.89
0.08
1.5
1.5
—
—
—
0
0
11
98
1.12
0.07
1.1
1.4
—
—
—
0
0
6
75
0.80
0.07
2.2
3.4
60.57
56.33
u/ml
—
6
75
8
95
0.84
0.06
1.3
1.1
—
—
—
0
0
11
99
1.11
0.06
1.1
1.4
—
—
—
0
0
11
99
1.11
0.06
1.1
1.4
—
—
—
0
0
22
233
0.94
0.06
2.1
1.8
2.93
2.92
mg/l
0.01
16
176
11
100
1.10
0.05
1.1
1.4
—
—
—
0
0
11
100
1.10
0.05
1.1
1.4
—
—
—
0
0
11
100
1.10
0.05
1.1
1.4
—
—
—
0
0
14
130
1.08
0.04
1.1
2.2
8.83
3567.79
u/l
—
7
49
214
2122
1.01
0.03
3.4
3.1
6.56
7.17
mmol/l
1.40
183
1777
16
151
1.06
0.03
1.4
1.3
271.86
238.80
miu/ml
—
7
65
217
2154
1.01
0.03
3.9
3.7
10.38
7.36
mg/mmol
0.56
147
1295
88
892
0.98
0.02
4.7
4.6
32.08
32.44
%
0.13
65
590
11
117
0.94
0.01
1.1
1.7
—
—
—
0
0
15
155
0.97
0.00
2.3
3.7
26.71
27.68
mg/l
—
7
97
10
103
0.97
0.00
1.1
1.6
—
—
—
0
0
10
103
0.97
0.00
1.8
1.5
—
—
—
0
0
19
188
1.01
0.00
1.2
1.3
—
—
—
0
0
10
99
1.01
0.00
1.7
1.4
—
—
—
0
0
10
99
1.01
0.00
1.7
1.4
—
—
—
0
0
60
598
1.00
0.00
2.9
2.4
29.83
35.11
u/l
0.80
54
504
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
7.9
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
10
100
1.00
-0.00
1.7
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
9
92
0.98
-0.00
1.0
1.7
—
—
—
0
0
10
100
1.00
-0.00
1.7
1.4
—
—
—
0
0
7
69
1.01
-0.00
1.0
1.8
—
—
—
0
0
7
79
0.89
-0.00
1.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.8
—
—
—
0
0
9
92
0.98
-0.00
1.1
1.6
—
—
—
0
0
6
65
0.92
-0.00
1.7
1.3
0.21
0.37
nmol/l
—
6
49
6
62
0.97
-0.00
1.7
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
117.86
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
8
84
0.95
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
8
84
0.95
-0.00
1.8
1.4
0.79
0.65
nmol/l
—
8
79
Mortality – FinRegistry
↥Association
Association between endpoint H7_CONJUNCTDEGDEPOT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUNCTDEGDEPOT | 1.186 [1.08, 1.3] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.208 |
During the follow-up period (1.1.1998 — 31.12.2019), 778 out of 3296 females with H7_CONJUNCTDEGDEPOT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H7_CONJUNCTDEGDEPOT | 1.055 [0.94, 1.19] | 0.384 |
| Birth year | 0.986 [0.98, 0.99] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 474 out of 1823 males with H7_CONJUNCTDEGDEPOT died.
Mortality risk
Mortality risk for people of age
years, who have H7_CONJUNCTDEGDEPOT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.14% | 0.185% |
| 5 | 0.716% | 1.11% |
| 10 | 1.788% | 3.068% |
| 15 | 3.429% | 5.735% |
| 20 | 5.936% | 9.686% |
Relationships between endpoints
↥Index endpoint: H7_CONJUNCTDEGDEPOT – conjunctival degenerations and deposits
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data